- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this study is to investigate the safety and efficacy of the UK-390,957 individual flexible dose group (including doses up to 10 mg) compared to placebo. Efficacy will be assessed using IELT at Week 8 and adverse events will be summarized by treatment arm.
Inclusion criteria
- premature ejaculation